[EN] SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME<br/>[FR] MODULATEURS CYCLIQUES SUBSTITUÉS DE PROTÉINE PHOSPHATASE 2A (PP2A) ET LEURS PROCÉDÉS D'UTILISATION
申请人:RAPPTA THERAPEUTICS OY
公开号:WO2022167867A1
公开(公告)日:2022-08-11
The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
本公开涉及部分蛋白磷酸酶2A(PP2A)的化学调节剂。本公开的化合物可用于治疗、预防和/或改善癌症、糖尿病、自身免疫性疾病、固体器官移植排斥、移植物抗宿主病、慢性阻塞性肺疾病(COPD)、非酒精性脂肪性肝病、腹主动脉瘤、慢性肝病、心力衰竭、神经退行性疾病和心肌肥厚。